A single-arm study on the effects of providing information and guidance about nutritional supplements containing amino acids for the patients receiving hematopoietic stem cell transplantation.

A single-arm study on the effects of providing information and guidance about nutritional supplements containing amino acids for the patients receiving hematopoietic stem cell transplantation. - Effects of information and guidance about supplements containing amino acids for the patients receiving HSCT.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000019608

Enrollment

Registered

2015-11-10

Start date

2015-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients who are received hematopoietic stem cell transplantation (autologous or allogeneic)

Interventions

Providing information and guidance about taking supplements containing amino acids (before therapy).

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: All patients with hematological malignancy who need hematopoietic transplantation.

Exclusion criteria

Exclusion criteria: Patients who reject to participate in this trial, or who are in condition of being unable to make conscious judgment.

Design outcomes

Primary

Measure	Time frame
Duration and Amounts of taking supplements	—

Secondary

Measure	Time frame
grade of mucotitis, periods for opioids-use, fasting and discharge, change of body weight, laboratory data, overall survival, incidence of GVHD	—

Countries

Japan

Contacts

Public ContactYuji Shimura

Kyoto Prefectural University of Medicine Dept. of Hematology

yshimura@koto.kpu-m.ac.jp075-251-5740

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026